Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in Southeast Asia has been experiencing significant growth in recent years.
Customer preferences: Customers in Southeast Asia are increasingly seeking out high-quality and affordable pharmaceutical products. This has led to a rise in demand for both generic and branded medicines, as well as an increase in the use of over-the-counter drugs. In addition, there is a growing trend towards natural and alternative medicines, as consumers become more health-conscious and seek out products that are perceived as being more natural and less harmful.
Trends in the market: In Indonesia, the largest pharmaceutical market in Southeast Asia, the government has been taking steps to increase access to healthcare for its citizens. This has led to an expansion of the pharmaceutical industry, with both domestic and international companies investing in the market. In addition, there has been a trend towards the development of biosimilars, which are cheaper alternatives to expensive biologic drugs.In Thailand, the government has been promoting the development of the pharmaceutical industry as part of its efforts to become a hub for medical tourism. This has led to an increase in the production of generic drugs, as well as a rise in the number of clinical trials being conducted in the country.In the Philippines, the government has been implementing reforms to improve access to healthcare and reduce the cost of medicines. This has led to an increase in the use of generic drugs, as well as a rise in the production of locally manufactured pharmaceutical products.
Local special circumstances: One of the main challenges facing the pharmaceutical industry in Southeast Asia is the lack of regulatory harmonization across the region. Each country has its own set of regulations and requirements, which can make it difficult for companies to operate in multiple markets. In addition, there are issues with intellectual property rights and counterfeiting, which can pose a significant risk to both consumers and companies.
Underlying macroeconomic factors: The growth of the pharmaceutical industry in Southeast Asia is being driven by a number of underlying macroeconomic factors. These include rising incomes, a growing middle class, and an aging population. In addition, there is a trend towards urbanization, which is leading to an increase in demand for healthcare services. Finally, there is a growing awareness of the importance of healthcare and wellness, which is driving demand for pharmaceutical products across the region.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)